FNK-92820-32757
2 vaccinations
5 coded responses
20 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 229 / VA
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-09
Registered in v-safe
-
2021-01-09
Dose 1 — Pfizer-BioNTech
-
2021-01-09
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: A little soreness at injection site. Minor. Mild.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
-
2021-01-30
Dose 2 — Pfizer-BioNTech
- 2021-01-30
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Abnormal dreams, Dizziness, Insomnia, Poor quality sleep — Feeling: Fair · HeadacheFree text: Sleep was impaired, did not sleep well. When I did sleep I had exaggerated dreams. Also felt faint this am. Went back to bed.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
- 2021-02-02
-
2021-02-03
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Insomnia — Feeling: Good · Fatigue or tirednessFree text: Inability to sleep. Tired.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Abnormal dreams — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: I continue to have vivid exaggerated dreams. Similar to when I took malaria prevention.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Abnormal dreams, Dizziness, Insomnia — Feeling: GoodFree text: Have not had any dizziness since Sunday. Still have exaggerated vivid dreams and ability to sleep is so so.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-02-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Pfizer-BioNTech | |
| 2 | 2021-01-30 | Pfizer-BioNTech |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): A little soreness at injection site. Minor. Mild.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Sleep was impaired, did not sleep well. When I did sleep I had exaggerated dreams. Also felt faint this am. Went back to bed.
Systemic reaction (other): Inability to sleep. Tired.
Systemic reaction (other): I continue to have vivid exaggerated dreams. Similar to when I took malaria prevention.
Systemic reaction (other): Have not had any dizziness since Sunday. Still have exaggerated vivid dreams and ability to sleep is so so.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Abnormal dreams | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Poor quality sleep | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release